Oragenics, Inc.
AMEXOragenics enters what may be its most watched week in months — Q1 results just dropped Thursday, with a second event scheduled for May 11, and the borrow market is as tight as it has been all year. Short sellers have built a formidable position. Short interest is 16.2% of the free float, or roughly 676,000 shares, even after a steady bleed lower over the past month — down about 7%…
OGEN SI utilization hits 92.62%, near 52-week peak of 100% — borrowing costs surge to 31.99% as short sellers face tight conditions.
Snapshot as of 23 Jun 2026
Oragenics enters what may be its most watched week in months — Q1 results just dropped Thursday, with a second event scheduled for May 11, and the borrow market is as tight as it has been all year. Short sellers have…
Oragenics, Inc. reports on May 11 with short sellers holding a position that leaves little ambiguity about market sentiment. Short interest is the defining feature of this setup. At 16.2% of the free float, the bearish…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for OGEN — free to start on ORTEX.
Sign up for free →Open OGEN on ORTEX